Non-trough adalimumab and certolizumab drug levels associated with a therapeutic EULAR response in adherent patients with rheumatoid arthritis. (2023)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/rheumatology/keac564
PubMed Identifier: 36190343
Publication URI: http://europepmc.org/abstract/MED/36190343
Type: Journal Article/Review
Volume: 62
Parent Publication: Rheumatology (Oxford, England)
Issue: 6
ISSN: 1462-0324